July 22, 2019
Nitto Pharmaceutical Industries Managing Director Kohei Kitao Nitto Pharmaceutical Industries, which is developing drugs using intestinal bacteria, will enhance its efforts to conduct formulation and non-clinical safety studies, with a research institute set up this spring. It aims to launch...read more